- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04154423
Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study (EMBRACE)
May 9, 2023 updated by: University of California, San Francisco
Comparing Approaches to Enhanced Prenatal Care to Improve Maternal and Child Health in Central CA
This is a randomized comparative effectiveness study of two forms of enhanced prenatal care among 2,600 Medi-Cal eligible pregnant women in Fresno, California.
The goal is to see whether group prenatal care with wrap around services versus individual prenatal care supplemented by services covered by the California Department of Public Health Comprehensive Perinatal Services Program (CPSP) results in lower rates of preterm birth, less depression and anxiety, and more respectful and greater satisfaction with prenatal care.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
2600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Miriam Kuppermann, PhD, MPH
- Phone Number: (415) 502-4089
- Email: miriam.kuppermann@ucsf.edu
Study Contact Backup
- Name: Lauren Lessard, PhD, MPH
- Email: llessard@csufresno.edu
Study Locations
-
-
California
-
Fresno, California, United States, 93710
- Recruiting
- Central Valley Health Policy Institute
-
Contact:
- Mary Garza, PhD
- Email: magarza@csufresno.edu
-
Contact:
- Miriam Kuppermann, PhD, MPH
- Email: miriam.kuppermann@ucsf.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Between 8 and 20 weeks gestation at enrollment
- Eligible for Medi-Cal (at or below 213% of the federal poverty level)
- Speak English or Spanish
Exclusion Criteria:
- Unavailable to attend group prenatal care sessions
- Not planning to continue prenatal care with site provider
- Cannot legally consent to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Glow! Group Prenatal Care
Group prenatal care with wrap around services.
|
Glow! is an enhanced group prenatal care model that offers co-located social services provided by established community programs with independent funding streams targeting low-income families.
The Glow! group prenatal care model pairs a trained facilitator with a licensed prenatal care practitioner from a practice site to provide billable prenatal care to the practice's own patients.
Over the course of 8-10 sessions, 10-12 women (within a 6- week gestational age range) receive prenatal medical care, risk assessments, and social support, and gain knowledge and skills related to pregnancy, birth, and parenting.
|
Active Comparator: Individual Prenatal Care- CPSP
Individual prenatal care with supplemental services covered by CPSP.
|
Comprehensive Perinatal Services Program (CPSP) is a state-funded program for Medi-Cal eligible families to receive enhanced care and service coordination.
Participants assigned to CPSP individual care may participate in the CPSP assessments with a Comprehensive Perinatal Health Worker at their prenatal care site, where individual prenatal care will be provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preterm birth
Time Frame: 0-12 weeks after delivery
|
Whether the participant had a baby born less than 37 weeks gestation, as noted in the participant's medical record.
|
0-12 weeks after delivery
|
Changes in depressive symptom severity
Time Frame: Collected from study enrollment to three months postpartum
|
Changes in depressive symptom severity from baseline to postpartum.
Assessed using the Patient Health Questionnaire (PHQ-9) developed by Kroenke et al. (2001), administered in-person at baseline and during telephone interview at three months postpartum.
|
Collected from study enrollment to three months postpartum
|
Perceptions of respectful/disrespectful care
Time Frame: Collected during third trimester and at three months postpartum
|
Extent to which the participant feels that the prenatal care they received was respectful.
Assessed using the Mothers on Respect Index (MORi) developed by Vedam et al. (2017), administered during telephone interview or in-person at third trimester and three months postpartum.
|
Collected during third trimester and at three months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gestational age at delivery
Time Frame: 0-12 weeks after delivery
|
The gestation age at which the baby was born (number of weeks), as noted in the participant's medical record.
|
0-12 weeks after delivery
|
Changes in anxiety symptom severity
Time Frame: Collected from study enrollment to three months postpartum
|
Changes in anxiety symptom severity from baseline to postpartum.
Assessed using the 7-item Generalized Anxiety Disorder (GAD-7) scale developed by Spitzer et al. (2006), administered in-person at baseline and during telephone interview at three months postpartum.
|
Collected from study enrollment to three months postpartum
|
Satisfaction with prenatal care
Time Frame: Collected during third trimester and at three months postpartum
|
Extent to which the participant feels satisfied with the prenatal care they received.
Assessed using the Prenatal Care Satisfaction (PSQ) Scale developed by Raube et al. (1998), administered during telephone interview or in-person interview at third trimester and three months postpartum.
|
Collected during third trimester and at three months postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Miriam Kuppermann, PhD, MPH, University of California, San Francisco
- Principal Investigator: Lauren Lessard, PhD, MPH, California State University, Fresno
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
- Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
- Raube K, Handler A, Rosenberg D. Measuring satisfaction among low-income women: a prenatal care questionnaire. Matern Child Health J. 1998 Mar;2(1):25-33. doi: 10.1023/a:1021841508698.
- Vedam S, Stoll K, Rubashkin N, Martin K, Miller-Vedam Z, Hayes-Klein H, Jolicoeur G; CCinBC Steering Council. The Mothers on Respect (MOR) index: measuring quality, safety, and human rights in childbirth. SSM Popul Health. 2017 Jan 19;3:201-210. doi: 10.1016/j.ssmph.2017.01.005. eCollection 2017 Dec.
- Peek ME, Nunez-Smith M, Drum M, Lewis TT. Adapting the everyday discrimination scale to medical settings: reliability and validity testing in a sample of African American patients. Ethn Dis. 2011 Autumn;21(4):502-9.
- Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med. 2005 Oct;61(7):1576-96. doi: 10.1016/j.socscimed.2005.03.006. Epub 2005 Apr 21.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 7, 2019
Primary Completion (Anticipated)
September 30, 2024
Study Completion (Anticipated)
September 30, 2024
Study Registration Dates
First Submitted
October 31, 2019
First Submitted That Met QC Criteria
November 4, 2019
First Posted (Actual)
November 6, 2019
Study Record Updates
Last Update Posted (Estimate)
May 11, 2023
Last Update Submitted That Met QC Criteria
May 9, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AD-2018C2-13227
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on Glow! Group Prenatal Care
-
Yale UniversityUnited Health FoundationCompletedSexually Transmitted Diseases | Premature Birth | Pregnancy | Infant, Low Birth Weight | Postpartum PeriodUnited States
-
Meir Medical CenterCompleted
-
Washington University School of MedicineDenver Health Medical CenterCompleted
-
Washington University School of MedicineActive, not recruitingPregnancy | Type 2 Diabetes | Gestational DiabetesUnited States
-
Washington University School of MedicineEnrolling by invitation
-
Washington University School of MedicineEnrolling by invitationElevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC)Pregnancy Related | Perinatal DepressionUnited States
-
Yale UniversityBrown UniversityCompleted
-
Penn State UniversityNational Heart, Lung, and Blood Institute (NHLBI); Arizona State UniversityCompletedPhysical Activity | Overweight and Obesity | Eating Behavior | Weight Change, BodyUnited States
-
Oswaldo Cruz FoundationMontefiore Medical CenterUnknown
-
University of Kansas Medical CenterCompleted